Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Rheum Dis. 2014 Aug;21(4):201-204. Korean. Case Report. https://doi.org/10.4078/jrd.2014.21.4.201
Yim SW , Byon CK , Park JY , Lee SY , Lee SW , Chung WT .
Division of Rheumatology, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea. wtchung@dau.ac.kr
Abstract

Rituximab is a chimeric murine-human monoclonal antibody that is directed against the specific B-cell CD20 antigen, which has recently been successfully used in active or refractory systemic lupus erythematosus (SLE) manifestations, such as nephritis, thrombocytopenia, and vasculitis. We report a case of a 25-year-old woman diagnosed with diffuse alveolar hemorrhage of SLE refractory to steroid pulse therapy. The patient was treated successfully with rituximab as a part of the immunosuppressive regimen.

Copyright © 2019. Korean Association of Medical Journal Editors.